Evaluation of 62 Saudi Arabs with alopecia areata on monthly intralesional injection of triamcinolone acetonide, showed complete regrowth in 40 (63%) patients at 4 months. Regrowth was likely in young adults with few lesions (less than 5 patches), lesions of short durations (less than 1 month) patches less than 3 cm in diameter. Regrowth was poor when associated with atopy (2 patients) and mongolism (1 patient). Side effects of treatment were minimal and the drug was well tolerated.